• / Free eNewsletters & Magazine
  • / My Account

CROs

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Bristol-Myers Squibb Selects Medidata Clinical Cloud® to Drive Drug Development and Business Transformation

    Bristol-Myers Squibb Selects Medidata Clinical Cloud® to Drive Drug Development and Business Transformation

  2. Viral Clearance Market by Application, Method & End User - Global Forecast to 2020 - Research and Markets

    Viral Clearance Market by Application, Method & End User - Global Forecast to 2020 - Research and Markets

  3. Late-Stage Businesses Drive Narrow Moats for CROs

    The top contract research organizations have opportunities to gain share in a rapidly growing industry.

  4. Increased Focus on Combination Therapies a Key Trend to Boost the Global Dermatophytic Onychomycosis Market Through 2020, says Technavio

    Increased Focus on Combination Therapies a Key Trend to Boost the Global Dermatophytic Onychomycosis Market Through 2020, says Technavio

  5. Health Care’s Outlook Clarifies

    Obamacare will benefit some sectors more than others, but poor economy and pricing pressures are the biggest challenges most health-care firms must face.

  6. Amid Turmoil, Don’t Discount Foreign Equities

    Use this screen to find overlooked small- and mid-cap international stocks.

  7. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.